A Single Dose of Psilocybin May Rewire the Brain for Lasting Relief
A single dose of psilocybin reduced pain and depression-like behaviors in mice for nearly two weeks, offering a potential non-opioid treatment for chronic pain and mood disorders.
3 Articles
3 Articles
A single dose of psilocybin may rewire the brain for lasting relief
Penn researchers found that psilocybin can calm brain circuits tied to pain and mood, easing both physical suffering and emotional distress in animal studies. The compound works in the anterior cingulate cortex, bypassing injury sites and offering a dual benefit for pain and depression. Unlike opioids, psilocybin is non-addictive and may provide relief lasting weeks.
Psilocybin targets brain circuits to relieve chronic pain and depression, study suggests
Researchers at Penn Medicine have identified specific brain circuits that are impacted by psilocybin—the active compound found in some psychedelic mushrooms—which could lead to new paths forward for pain and mental health management options.
Psilocybin Rewire Brain Circuits Tied to Pain and Mood
New research shows that psilocybin, the active compound in psychedelic mushrooms, can reduce both chronic pain and pain-related depression by modulating brain circuits rather than acting at the site of injury. In mouse studies, a single dose provided pain relief and mood benefits lasting nearly two weeks by targeting the anterior cingulate cortex.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium